GlassScriptPhysician profile
Larry H Mufson
NPI 1174583975
$6,117.95
in general payments reported to CMS, 2019-2025
30 companies · $617 in 2025
The $617 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $952 · 2020: $631 · 2021: $940 · 2022: $1,126 · 2023: $711 · 2024: $1,141 · 2025: $617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,452 · Education: $17.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,451.85 |
| Education | $17.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,003.38 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $830.17 | 2019-2025 | Eliquis, Camzyos |
| Janssen Pharmaceuticals, INC | $821.75 | 2019-2024 | Xarelto |
| Abbott Laboratories | $656.52 | 2020-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Amplatzer Amulet |
| Amgen INC. | $388.07 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $387.97 | 2019-2025 | |
| Medtronic, INC. | $379.74 | 2021-2024 | Aurora Ev-Icd Mri Surescan, Micra, Azure Xt Dr Mri Surescan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $236.40 | 2019-2023 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $216.41 | 2019-2025 | Lokelma, Farxiga |
| Sanofi-Aventis U.S. LLC | $203.49 | 2019-2023 | |
| Actelion Pharmaceuticals US, INC. | $117.54 | 2023-2025 | Uptravi, Opsumit |
| Bayer Healthcare Pharmaceuticals INC. | $108.84 | 2022-2024 | |
| Regeneron Healthcare Solutions, INC. | $101.22 | 2019-2025 | Evkeeza, Praluent |
| Merck Sharp & Dohme LLC | $94.28 | 2022-2025 | Verquvo |
| Boston Scientific Corporation | $92.78 | 2022-2025 | Watchman Flx |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $92.24 | 2022-2025 | Ozempic, Wegovy |
| Heartflow, INC. | $68.34 | 2025 | |
| Lundbeck LLC | $50.64 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $48.40 | 2024-2025 | Lifevest |
| Alnylam Pharmaceuticals INC. | $39.67 | 2025 | Onpattro |
| Biosense Webster, INC. | $30.37 | 2021 | |
| United Therapeutics Corporation | $20.30 | 2024 | Tyvaso |
| Kowa Pharmaceuticals America, INC. | $18.58 | 2019 | |
| Irhythm Technologies, INC. | $18.21 | 2024 | Zio Xt Patch, Zio Monitor |
| Scpharmaceuticals INC. | $17.89 | 2024 | |
| Agepha Pharma Fz LLC | $17.88 | 2024 | Lodoco |
| Esperion Therapeutics, INC. | $15.22 | 2021 | |
| Cvrx, INC. | $14.24 | 2024 | Barostim Neo System |
| Akcea Therapeutics, INC. | $13.86 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $13.55 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Mufson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.